ALPINE: Maintenance Letrozole/Abemaciclib
ALPINE: Maintenance Letrozole/Abemaciclib
Recruiting · NCT06366347 · Registry updated 2026-09-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ALPINE: Maintenance Letrozole/Abemaciclib | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorder | Recruiting | Phase 2 | 2026-09-16 | NCT06366347 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Dana-Farber Cancer Institute | 324 |
| Eli Lilly and Company | 370 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Brigham and Women's Hospital | Boston | United States | 60 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |
| Dana-Farber Cancer Institute at Foxborough | Foxborough | United States | 17 |
| Dana-Farber Cancer Institute at Milford | Milford | United States | 2 |
| Dana-Farber Cancer Institute at South Shore Hospital | Weymouth | United States | 1 |